Schlagwort: Sachs
Neue Mehrheiten
Deutschland steht davor, Mehrstimmrechte bei Namensaktien wieder einzuführen. Auslöser sind der EU Listing Act und das deutsche Zukunftsfinanzierungsgesetz (ZuFinG), die beide das Ziel verfolgen,...
20th Annual Biotech in Europe Forum
The 20th Annual Biotech in Europe Forum is recognised as the leading international stage for those interested in investing and partnering in the biotech and...
5th Annual Immuno-oncology BD&L and Investment Forum
Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes,...